Patent AT-E401338-T1: [Translated] CITRULLINE PEPTIDES DERIVED FROM FIBRIN RECOGNIZED BY AUTOANTIBODIES SPECIFIC TO RHEUMATOID ARTHRITIS AND THE USE THEREOF

The invention relates to novel citrulline peptides derived from fibrin α and β chains which are recognizable by specific citrulline antiprotein autoantibodies (AAPC) of a rheumatoid arthritis (PR) and to the use thereof for detecting the presence of said specific PR AAPC in a biological sample.